Search
Lifecore Biomedical Inc
LFCRAdd to Watchlist
5.090USD
-0.180-3.42%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
190.76MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-3.42%
5 Days
-1.55%
1 Month
-12.09%
6 Months
-34.24%
Year to Date
-37.78%
1 Year
-36.69%
Key Figures
5.270Open
5.490High
121.55KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.32%Turnover Ratio
5.270Prev. Close
5.080Low
455.30KTurnover
LossP/E Static
-6.71P/B
0.00%Div Yield TTM
-3.54%ROA
8.98052wk High
0.48Volume Ratio
-44.36MNet Profit
37.48MShares
-0.1069EPS TTM
1.07Beta
-701.27%ROE
3.62552wk Low
7.78%Amplitude
19.24%Gross Margin
190.76MMarket Cap
-2.45Reward/Risk
3.67%Risk Rate
TradingKey Stock Score of Lifecore Biomedical Inc
Currency: USD Updated: 2026-07-02Key Insights
Lifecore Biomedical Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 80 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 6.83.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Lifecore Biomedical Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Lifecore Biomedical Inc Highlights
StrengthsRisks
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.
Growing
The company is in a growing phase, with the latest annual income totaling USD 75.52M.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Undervalued
The company’s latest PE is -47.61, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 30.56M shares, increasing 3.27% quarter-over-quarter.
Held by Steven Cohen
Star Investor Steven Cohen holds 19.62K shares of this stock.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
6.833
Target Price
+29.66%
Upside Space
Lifecore Biomedical Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Lifecore Biomedical Inc Info
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.
Ticker SymbolLFCR
CompanyLifecore Biomedical Inc
CEOJosephs (Paul)
Websitehttps://www.lifecore.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Lifecore Biomedical Inc (LFCR)?
The current price of Lifecore Biomedical Inc (LFCR) is 5.09.
What is the symbol of Lifecore Biomedical Inc?
The ticker symbol of Lifecore Biomedical Inc is LFCR.
What is the 52-week high of Lifecore Biomedical Inc?
The 52-week high of Lifecore Biomedical Inc is 8.98.
What is the 52-week low of Lifecore Biomedical Inc?
The 52-week low of Lifecore Biomedical Inc is 3.62.
What is the market capitalization of Lifecore Biomedical Inc?
The market capitalization of Lifecore Biomedical Inc is 190.76M.
Is Lifecore Biomedical Inc (LFCR) currently rated as Buy, Hold, or Sell?
According to analysts, Lifecore Biomedical Inc (LFCR) has an overall rating of Buy, with a price target of 6.83.
What is the Earnings Per Share (EPS TTM) of Lifecore Biomedical Inc (LFCR)?
The Earnings Per Share (EPS TTM) of Lifecore Biomedical Inc (LFCR) is -0.54.